Background: Human papillomavirus (HPV)-associated anogenital ... Materials & methods: Original papers on the treatment of external anogenital warts were included in a meta-analysis to assess ...

The ongoing trial is assessing the drug's performance both as a standalone therapy and in combination with Keytruda.

INOVIO (NASDAQ: INO) has unveiled encouraging new immunology data for its lead product candidate, INO-3107, which is designed ...

We have powerful vaccines that can prevent infection with the human papillomavirus (HPV) that causes cervical cancer; we have ...

According to DelveInsight’s analysis, the human papillomavirus market is anticipated to increase during the forecast period (2024–2034), owing to the launch of emerging therapies and healthcare ...

Information and resources for understanding human papillomavirus ... WebMD quizzes you about HPV symptoms, HPV treatments, HPV prevention, and more.

announces that the first patient has been enrolled in the Phase I/IIa clinical trial evaluating the onco-therapeutic vaccine Lenti-HPV-07 for the treatment of human papillomavirus (HPV)-induced ...

Cases of mouth cancer have reached a record high in England and Scotland, a new report shows. Last year, there were more than ...

The story of a man in China who lost all his money due to misdiagnosis of the HPV virus (human papilloma virus) has been ...

Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S. drugmaker's ...

Clearance rates were 0–6.5% for placebo treatment, 76.6% for podophyllotoxin 0.15% cream administered for 4 weeks, 61.5% for podophyllotoxin 0.5% solution (2–6 weeks) and 53.7% for imiquimod 5 ...